Bank Of America Corp Edesa Biotech, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.72 - $5.97 $43 - $95	-16 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$5.17 - $8.65 $82 - $138	16 New	16 $0
Q3 2021 Nov 15, 2021	SELL	$4.2 - $11.92 $201 - $572	-48 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$4.93 - $6.69 $236 - $321	48 New	48 $0

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $66.3M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.